title: Reply to Ekeoduru, Rhashedah; Matuszczak, Maria; Lin, Michael, regarding their comment 'Correspondence' regarding 'The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex' by Langley, McFadzean & McCormack.
authors.affiliation: Department of Paediatric Anaesthesia, Royal Hospital for Sick Children, Edinburgh, UK. jonmccormack@nhs.net.
authors.forename: Jon G
authors.initials: JG
authors.lastname: McCormack
authors.affiliation: Department of Paediatric Critical Care, Royal Hospital for Sick Children, Edinburgh, UK.
authors.forename: Ross
authors.initials: R
authors.lastname: Langley
authors.affiliation: Department of Paediatric Critical Care, Royal Hospital for Sick Children, Edinburgh, UK.
authors.forename: Jillian
authors.initials: J
authors.lastname: McFadzean
mesh_terms: D000732:Androstanols; D006801:Humans; D007231:Infant, Newborn; D009420:Nervous System / Q000187:drug effects; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium